NX-1607

1 clinical trials involving this therapy/drug

This is not medical advice - consult your oncologist

Descriptions are automatically translated with AI assistance. Always verify details in the original on ClinicalTrials.gov and consult your treating physician.

RecruitingPhase IBreast cancerLung cancerOvarian cancerCervical cancerColorectal cancerGastric cancerLymphomaMelanomaProstate cancerBladder cancerHead and neck cancerOther cancersTriple negative (TNBC)Metastatic / advanced

A Study of NX-1607 in Adults With Advanced Malignancies

NCT05107674ClinicalTrials.gov ↗

This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced malignancies.

Full details →

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.